https://www.pymnts.com/cpi-posts/us-ags-file-complaint-against-generic-drugmakers/
PYMNTS | US AGs File Complaint Against Generic Drugmakers
Jun 10, 2020 - A coalition of 51 attorneys general in the US filed an antitrust complaint in federal court alleging that key individual executives and manufacturers of...
agsfilecomplaintgenericdrugmakers
https://kffhealthnews.org/health-industry/drugmakers-manipulate-orphan-drug-rules-to-create-prized-monopolies/
Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies - KFF Health News
Apr 18, 2026 - Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed...
kff health newsorphan drugto createdrugmakersmanipulate
https://edelic.org/biography-memoir/after-fda-setback-psychedelic-drugmakers-distance-themselves-from-a-pioneer/
After FDA setback, psychedelic drugmakers distance themselves from a pioneer – ECFES
fdasetbackpsychedelicdrugmakersdistance
https://health.economictimes.indiatimes.com/tag/indian+drugmakers
Indian drugmakers - Latest indian drugmakers , Information & Updates - Health -ET HealthWorld
ETHealthworld.com brings latest indian drugmakers news, views and updates from all top sources for the Indian Health industry.
indiandrugmakerslatestinformationupdates
https://ahrp.org/drugmakers-go-furthest-to-sway-congress-1274-lobbyists-usa-today/
Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists - USA Today | Alliance for Human Research...
Nov 22, 2014 - Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists - USA Today Tue, 26 Apr 2005 USA Today provides a glimpse into the way the pharmaceutical industry...
usa todayhuman researchdrugmakersfurthestsway
https://www.chemdiv.com/company/media/pharma-news/2018/drugmakers-tout-new-medicines-eye-disease-battle-intensifies/
Drugmakers tout new medicines as eye disease battle intensifies - Chemdiv
Drugmakers tout new medicines as eye disease battle intensifies
new medicineseye diseasedrugmakerstoutbattle
https://www.financialexpress.com/policy/economy-indian-drugmakers-get-tariff-relief-from-the-us-on-specialty-drugs-4349994/
Indian drugmakers get tariff relief from the US on specialty drugs - Economy News | The Financial...
India is among 19 jurisdictions eligible for zero tariffs on certain specialty medicines under the US Section 232 exemption, benefiting companies like Sun...
from thespecialty drugseconomy newsindiandrugmakers
https://insuresolve.com/hrsa-names-10-drugmakers-for-revised-340b-rebate-pilot-ahead-of-2027-launch/
10 Essential Drugmakers Achieving 340B Success Today
Oct 7, 2026 - Discover the 10 vital drugmakers named for 340B success. Learn how the latest updates to the 340B drug rebate program and new CMS requirements impact the...
essentialdrugmakersachievingsuccesstoday
https://www.kpbs.org/news/international/2021/10/27/merck-will-allow-drug-makers-in-other-countries-to-make-its-covid-19-pill
Merck will allow drugmakers in other countries to make its COVID-19 pill | KPBS Public Media
Mar 18, 2022 - The drug, known as molnupiravir, has shown promise in treating the disease.
kpbs public mediaother countriesto makemerckallow
https://corruption.news/2026-09-29-reddit-polices-health-claims-drugmakers-seek-access.html
Reddit polices health claims while drugmakers buy access to its users
Reddit quarantined 54 communities and banned r/NoNewNormal in 2021 amid demands to curb COVID-19 misinformation. Volunteer moderators set their own rules, so...
health claimsbuy accessredditpolicesdrugmakers
https://desaidiwanji.com/insights/articles/us-pharma-tariffs-and-implications-for-indian-drugmakers
US Pharma Tariffs and Implications for Indian Drugmakers | Desai & Diwanji
Sep 10, 2026 - On 25 September 2025, the United States announced the imposition of 100 per cent tariffs on imports of branded and patented pharmaceutical products, with…
pharmatariffsimplicationsindiandrugmakers
https://www.law360.com/lifesciences/articles/504064
Drugmakers Defend No-Cash Patent Deals Post-Actavis - Law360
Drugmakers are scrambling to limit the scope of the U.S. Supreme Court's landmark antitrust decision in Federal Trade Commission v. Actavis, arguing with mixed...
drugmakersdefendcashpatentdeals